Aerovate Therapeutics (AVTE) News Today → Thousands of investors use this no cost solution | Do you? (From Insider Financial) (Ad) Free AVTE Stock Alerts $22.27 +0.70 (+3.25%) (As of 10:02 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAerovate Therapeutics (NASDAQ:AVTE) Sees Large Volume Increasemarketbeat.com - April 24 at 6:15 PMBenjamin T. Dake Sells 6,853 Shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Stockinsidertrades.com - April 21 at 5:10 AMAerovate Therapeutics exec sells shares worth over $153,000investing.com - April 20 at 8:22 PMAerovate Therapeutics CEO sells over $246k in company stockinvesting.com - April 20 at 3:22 PMTimothy P. Noyes Sells 10,000 Shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Stockamericanbankingnews.com - April 20 at 5:18 AMInsider Selling: Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Insider Sells 6,853 Shares of Stockmarketbeat.com - April 19 at 6:45 PMAerovate Therapeutics, Inc. (NASDAQ:AVTE) CEO Sells $247,000.00 in Stockinsidertrades.com - April 19 at 6:53 AMAerovate Therapeutics (NASDAQ:AVTE) Stock Price Down 3.8%marketbeat.com - April 18 at 2:47 PMShort Interest in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Grows By 9.9%americanbankingnews.com - April 17 at 4:36 AMAerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Up 9.9% in Marchmarketbeat.com - April 15 at 10:35 AMInsider Selling: Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Insider Sells 7,500 Shares of Stockinsidertrades.com - April 13 at 7:09 AMAerovate Therapeutics (NASDAQ:AVTE) Trading Down 5.4% After Insider Sellingmarketbeat.com - April 12 at 12:24 PMAerovate Therapeutics, Inc. (NASDAQ:AVTE) Director Sells $334,478.30 in Stockinsidertrades.com - April 12 at 6:40 AMAerovate Therapeutics, Inc. (NASDAQ:AVTE) Director David S. Grayzel Sells 11,882 Sharesmarketbeat.com - April 11 at 6:34 PMAerovate Therapeutics (NASDAQ:AVTE) Trading Up 7.3%marketbeat.com - April 9 at 12:11 PMAerovate Therapeutics, Inc. (NASDAQ:AVTE) Insider Benjamin T. Dake Sells 3,325 Sharesinsidertrades.com - April 4 at 6:49 AMAerovate Therapeutics Inc CEO Timothy Noyes Sells 10,000 Sharesfinance.yahoo.com - April 4 at 2:17 AMAerovate Therapeutics (NASDAQ:AVTE) Trading Down 3.9%marketbeat.com - April 3 at 1:57 PMAerovate Therapeutics (NASDAQ:AVTE) Shares Gap Down to $30.75marketbeat.com - April 2 at 11:18 AMAerovate Therapeutics: Poised for Market Capitalization Growth on IMPAHCT Trial Successmarkets.businessinsider.com - April 2 at 8:59 AMAerovate Therapeutics (NASDAQ:AVTE) Stock Rating Reaffirmed by Wells Fargo & Companymarketbeat.com - April 1 at 12:23 PMAerovate Therapeutics (NASDAQ:AVTE) Reaches New 1-Year High at $30.73marketbeat.com - April 1 at 10:54 AMAerovate Therapeutics (NASDAQ:AVTE) on the Verge of Substantial Growthmsn.com - April 1 at 7:45 AMAerovate Therapeutics, Inc. (NASDAQ:AVTE) Sees Large Decline in Short Interestmarketbeat.com - March 31 at 9:10 PMAerovate Therapeutics, Inc. (NASDAQ:AVTE) Insider Benjamin T. Dake Sells 11,068 Sharesinsidertrades.com - March 29 at 8:40 AMAerovate Therapeutics, Inc. (NASDAQ:AVTE) Insider Sells 3,432 Sharesinsidertrades.com - March 28 at 8:45 AMAerovate Therapeutics (NASDAQ:AVTE) Shares Gap Up to $25.65marketbeat.com - March 27 at 11:47 AMAerovate Therapeutics to Present Patient Baseline Characteristics of the Phase 2b Portion of the Phase 2b/Phase 3 IMPAHCT Trial at the American Thoracic Society 2024 International Conferenceglobenewswire.com - March 27 at 9:20 AMAerovate Therapeutics Inc (AVTE) Reports Increased R&D Expenses and Net Loss in 2023finance.yahoo.com - March 27 at 5:13 AMAerovate Therapeutics (NASDAQ:AVTE) Trading Down 8.8%marketbeat.com - March 26 at 4:22 PMAerovate Therapeutics, Inc.: Aerovate Therapeutics Announces Full-Year 2023 Financial Results and Business Highlightsfinanznachrichten.de - March 26 at 8:31 AMAerovate Therapeutics (AVTE) to Release Earnings on Wednesdaymarketbeat.com - March 26 at 7:43 AMAerovate Therapeutics: A Strong Buy Ahead of Key Clinical Data Releasemarkets.businessinsider.com - March 26 at 3:30 AMRecap: Aerovate Therapeutics Q4 Earningsbenzinga.com - March 25 at 10:29 PMAVTE Stock Earnings: Aerovate Therapeutics Misses EPS for Q4 2023investorplace.com - March 25 at 10:03 PMAerovate Therapeutics Announces Full-Year 2023 Financial Results and Business Highlightsmarkets.businessinsider.com - March 25 at 5:28 PMAerovate Therapeutics Announces Full-Year 2023 Financial Results and Business Highlightsglobenewswire.com - March 25 at 4:10 PMAerovate Therapeutics (NASDAQ:AVTE) Reaches New 12-Month High at $28.39marketbeat.com - March 25 at 11:15 AMAerovate Therapeutics' (AVTE) "Buy" Rating Reiterated at Jefferies Financial Groupmarketbeat.com - March 25 at 8:48 AMAerovate Therapeutics Inc AVTEmorningstar.com - March 24 at 5:07 AMAerovate Therapeutics, Inc. (NASDAQ:AVTE) Insider Sells $138,224.00 in Stockinsidertrades.com - March 21 at 10:01 AMInsider Sell: Aerovate Therapeutics Inc's (AVTE) Chief Technical Officer Marinus Verwijs Sells ...finance.yahoo.com - March 21 at 3:56 AMChief Medical Officer Hunter Gillies Sells 7,000 Shares of Aerovate Therapeutics Inc (AVTE)finance.yahoo.com - March 21 at 3:56 AMGeorge A. Eldridge Sells 2,016 Shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Stockinsidertrades.com - March 16 at 6:32 AMAerovate Therapeutics (NASDAQ:AVTE) Sets New 1-Year High at $27.82marketbeat.com - March 13 at 4:46 PMAerovate Therapeutics (NASDAQ:AVTE) Sees Strong Trading Volumemarketbeat.com - March 12 at 2:34 PMAerovate Therapeutics, Inc. (NASDAQ:AVTE) Insider George A. Eldridge Sells 3,433 Sharesinsidertrades.com - March 12 at 5:20 AMAerovate Therapeutics (NASDAQ:AVTE) Trading Down 5.4%marketbeat.com - March 11 at 12:44 PMAerovate Therapeutics, Inc. (NASDAQ:AVTE) Shares Sold by Fmr LLCmarketbeat.com - March 9 at 4:21 AMAerovate Therapeutics (NASDAQ:AVTE) Shares Gap Down to $22.84marketbeat.com - March 6 at 1:54 PM Get Aerovate Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AVTE and its competitors with MarketBeat's FREE daily newsletter. Email Address What is Medicare Supplement Insurance? (Ad)Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you. Learn More Here AVTE Media Mentions By Week AVTE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVTE News Sentiment▼0.630.34▲Average Medical News Sentiment AVTE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVTE Articles This Week▼81▲AVTE Articles Average Week Get Aerovate Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AVTE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Longboard Pharmaceuticals News Today Bicycle Therapeutics News Today Y-mAbs Therapeutics News Today Pharming Group News Today ORIC Pharmaceuticals News Today Silence Therapeutics News Today SIGA Technologies News Today Zymeworks News Today PureTech Health News Today Praxis Precision Medicines News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AVTE) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss RatingsExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aerovate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
